Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience

Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience

Abstract Background Urothelial bladder carcinoma accounts for around 3.9% cases of all the male cancers in India. Non-muscle-invasive bladder carcinoma (NMIBC) is predominant group which constitute approximately three fourth of the urothelial bladder cancer. Intravesical BCG immunotherapy is the cor...

Full description

Bibliographic Details
Main Authors: Vivek Sharma, Avinash P. S. Thakur, Vasantharaja Ramasamy, Pushpendra Kumar Shukla, Fanindra Singh Solanki, Arpan Choudhary, Prashant Patel
Format: Article
Language:English
Published: SpringerOpen 2020-12-01
Series:African Journal of Urology
Subjects:
Intravesical BCG
Tuberculosis
Non-muscle-invasive bladder carcinoma
BCG toxicity
BCG cystitis
Online Access:https://doi.org/10.1186/s12301-020-00099-6

Internet

https://doi.org/10.1186/s12301-020-00099-6

Similar Items